Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-Guérin

J Urol. 2022 Sep;208(3):526-527. doi: 10.1097/JU.0000000000002779. Epub 2022 May 13.

Authors

Joshua J Meeks¹, Wade J Sexton², Peter E Clark³

Affiliations

¹ Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.
² Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida.
³ Atrium Health, Levine Cancer Institute, Charlotte, North Carolina.

PMID: 35549526
DOI: 10.1097/JU.0000000000002779

No abstract available

Publication types

Editorial

MeSH terms

Adjuvants, Immunologic / therapeutic use
Administration, Intravesical
BCG Vaccine / therapeutic use
Carcinoma, Transitional Cell* / drug therapy
Deoxycytidine / analogs & derivatives
Docetaxel / therapeutic use
Gemcitabine
Humans
Mycobacterium bovis*
Urinary Bladder Neoplasms* / drug therapy

Substances

Adjuvants, Immunologic
BCG Vaccine
Deoxycytidine
Docetaxel
Gemcitabine